HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effects of metalloproteinases-1 (TIMP-1) cDNA transfection on biological behaviors of PG cells].

Abstract
A recombinant plasmid, which contains a full length cDNA of human tissue inhibitor of metalloproteinases-1 (TIMP-1), was constructed by using gene recombinant technique, and introduced into a highly metastatic human giant cell carcinoma (PG) by lipofectin technique. Two of the transfectants, PG-T2 and PG-T4, were studied thoroughly. Northern blot showed an increased level of TIMP-1 mRNA in PG-T2 and PG-T4, compared with PG and PG-MV1 (vector-transfected control). The two transfectants also exhibited higher TIMP-1 protein activities. Moreover, they showed significant reduction in their proliferation rate and invasive abilities. The abilities of forming colonies in soft agar and tumorigenecity in athymic nude mice were abrogated in PG-T2 and PG-T4. The preliminary results suggest that a specific upregulation of TIMP-1 expression in metastatic cells could not only suppress their invasive and metastatic phenotype, but also inhibit their proliferation and tumorigenecity.
AuthorsK X Zhou, B Q Wu, J Zheng
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 74 Issue 7 Pg. 402-5, 454 (Jul 1994) ISSN: 0376-2491 [Print] China
PMID7987710 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Complementary
  • Glycoproteins
  • Tissue Inhibitor of Metalloproteinases
Topics
  • Animals
  • Carcinoma, Giant Cell (pathology)
  • DNA, Complementary (genetics)
  • Female
  • Glycoproteins (pharmacology)
  • Humans
  • Lung Neoplasms (pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Recombination, Genetic
  • Tissue Inhibitor of Metalloproteinases
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: